Additionally, MLX up-regulates Beclin-1 and IL-3 inducing autophagy and modulates the microRNA-200/PD-L1 pathway, increasing the sensitivity of tumor cells to immunotherapy [23,24,25]. This evidence concerns the gene MLX and neoplasm.